179 related articles for article (PubMed ID: 2106180)
1. Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms.
Hancock WW; DiStefano R; Braun P; Schweizer RT; Tilney NL; Kupiec-Weglinski JW
Transplantation; 1990 Feb; 49(2):416-21. PubMed ID: 2106180
[TBL] [Abstract][Full Text] [Related]
2. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
[TBL] [Abstract][Full Text] [Related]
3. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
[TBL] [Abstract][Full Text] [Related]
4. Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy.
Kupiec-Weglinski JW; Sablinski T; Hancock WW; Di Stefano R; Mariani G; Mix CT; Tilney NL
Transplantation; 1991 Feb; 51(2):300-5. PubMed ID: 1825240
[TBL] [Abstract][Full Text] [Related]
5. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
[TBL] [Abstract][Full Text] [Related]
6. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of a clinically relevant protocol to induce tolerance of cardiac allografts. Perioperative donor spleen cells plus cyclosporine suppress IL-2 and interferon-gamma production.
Salom RN; Maguire JA; Hancock WW
Transplantation; 1993 Dec; 56(6):1309-14. PubMed ID: 8278994
[TBL] [Abstract][Full Text] [Related]
8. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
Hancock WW; Sayegh MH; Sablinski T; Kut JP; Kupiec-Weglinski JW; Milford EL
Transplantation; 1992 Jun; 53(6):1276-80. PubMed ID: 1604485
[TBL] [Abstract][Full Text] [Related]
9. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection.
Candinas D; Belliveau S; Koyamada N; Miyatake T; Hechenleitner P; Mark W; Bach FH; Hancock WW
Transplantation; 1996 Dec; 62(12):1920-7. PubMed ID: 8990388
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts.
Ueda H; Hancock WW; Cheung YC; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
Transplantation; 1990 Oct; 50(4):545-50. PubMed ID: 2219270
[TBL] [Abstract][Full Text] [Related]
11. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
Kupiec-Weglinski JW; Wasowska B; Papp I; Schmidbauer G; Sayegh MH; Baldwin WM; Wieder KJ; Hancock WW
J Immunol; 1993 Nov; 151(9):5053-61. PubMed ID: 8409456
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
Tanaka K; Tilney NL; Stunkel KG; Hancock WW; Diamantstein T; Kupiec-Weglinski JW
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7375-9. PubMed ID: 2217171
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
Tanaka K; Hancock WW; Osawa H; Stunkel KG; Alberghini TV; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
J Immunol; 1989 Nov; 143(9):2873-9. PubMed ID: 2530281
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory effects of the alkaloid sinomenine in the high responder ACI-to-Lewis cardiac allograft model.
Candinas D; Mark W; Kaever V; Miyatake T; Koyamada N; Hechenleitner P; Hancock WW
Transplantation; 1996 Dec; 62(12):1855-60. PubMed ID: 8990376
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of interleukin 2 receptor-targeted therapy on heart and kidney allografts in rats. Depression of effectiveness of ART-18 monoclonal antibody treatment by uremia.
Ueda H; Hancock WW; Cheung YC; Tanaka K; Kupiec-Weglinski JW; Tilney NL
Transplantation; 1990 Jun; 49(6):1124-9. PubMed ID: 2113725
[TBL] [Abstract][Full Text] [Related]
16. Evidence that therapeutic strategies targeted at CD4+ cells modulate accelerated rejection of cardiac allografts in sensitized rats by different mechanisms.
Sablinski T; Sayegh MH; Kut JP; Milford EL; Tilney NL; Kupiec-Weglinski JW
Transplantation; 1992 Aug; 54(2):292-6. PubMed ID: 1353914
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
[TBL] [Abstract][Full Text] [Related]
18. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
Murphy B; Kim KS; Buelow R; Sayegh MH; Hancock WW
Transplantation; 1997 Jul; 64(1):14-9. PubMed ID: 9233694
[TBL] [Abstract][Full Text] [Related]
19. Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation.
Kupiec-Weglinski JW; Mariani G; Tanaka K; Di Stefano R; Stünkel KG; Diamantstein T; Tilney NL
Cell Immunol; 1989 Oct; 123(1):148-57. PubMed ID: 2476241
[TBL] [Abstract][Full Text] [Related]
20. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL
Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156
[No Abstract] [Full Text] [Related]
[Next] [New Search]
